Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Squalene-based adjuvants are oil-in-water emulsions that stimulate the innate immune system, leading to the recruitment and activation of antigen-presenting cells (APCs). This process enhances antigen presentation and promotes a robust adaptive immune response. The mechanism involves DAMP release, cytokine/chemokine cascades, and infiltration of innate immune cells like monocytes, neutrophils, and dendritic cells to the injection site. Ultimately this leads to enhanced B/Tfh/CD8+ T cell responses.
Squalene-based adjuvants induce local tissue damage, releasing DAMPs, which activate APCs via cytokine/chemokine signaling. This leads to innate immune cell recruitment, enhanced antigen presentation, and subsequent adaptive immune response.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate Immune System (Squalene-Adjuvant Mediated Activation) (N/A).